Almirall

N/A

UV sensor

Keratosis, Actinic

N/A

Clinical Trials (1)

NCT05481073UV Sensor in Patients With Actinic Keratosis

N/A

Study of Alloknesia in Atopic Dermatitis

Atopic Dermatosis

N/A

Clinical Trials (1)

NCT06923202Study of Alloknesia in Atopic Dermatitis

N/A

flexible patient centred consultations

Atopic Dermatitis

N/A

Clinical Trials (1)

NCT06032403Patient with Atopic Dermatitis' Needs for Self-management Support - Flexible Patient Centred Consultations

N/A

Spanish Registry of Systemic Treatments in Psoriasis

Chronic Obstructive Pulmonary Disease - COPD

N/A

Clinical Trials (1)

NCT02075697Spanish Registry of Systemic Treatments in Psoriasis

N/A

The Canadian Cohort Obstructive Lung Disease

COPD

N/A

Clinical Trials (1)

NCT00920348The Canadian Cohort Obstructive Lung Disease

N/A

LAS40468

Asthma

Phase 1

Clinical Trials (1)

NCT02094274A Single-dose, Randomised, Crossover, Placebo-controlled Study Assessing Two Fixed-dose Combinations of Inhaled Long-acting Beta-agonist and Corticosteroid

Phase 1

AZD8871

Phase 1

Clinical Trials (1)

NCT03159442Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of AZD8871 in Healthy Male Japanese Subjects

Phase 1

Onabotulinum Toxin Type A - Phase 1b

Atopic Dermatitis (AD)

Phase 1

Clinical Trials (1)

NCT06928246The Impact of Botox on Neuroimmune Interactions in Atopic Dermatitis

Phase 1

dapsone gel

Phase 1

Clinical Trials (1)

NCT02117752Dermal Tolerability of Dapsone Gel in Healthy Volunteers

Phase 1

dapsone gel

Phase 1

Clinical Trials (1)

NCT02108483Phototoxicity Test of Dapsone Gel in Healthy Volunteers

Phase 1

dapsone gel

Phase 1

Clinical Trials (1)

NCT02117739Photoallergy Potential of Dapsone Gel in Healthy Volunteers

Phase 1

LAD106

Phase 1

LAD328

Hidradenitis Suppurativa

Phase 2

Clinical Trials (1)

NCT07547813A Proof-of-Concept Study of LAD328 in Adults With Hidradenitis Suppurativa

Phase 2

LAS 41002

Atopic Eczema

Phase 2

Clinical Trials (1)

NCT01119313Study to Investigate Skin Conditions and Patient Assessment of LAS 41002 in the Treatment of Atopic Eczema

Phase 2

tazarotene

Nail Psoriasis

Phase 2

Clinical Trials (1)

NCT02235480Efficacy and Safety of Tazarotene Gel in Nail Psoriasis

Phase 2

50 mg P005672-HCl

Phase 2

Clinical Trials (1)

NCT01628549Double-Blind, Placebo-Controlled Study to Evaluate 3 Doses of a Novel Tetracycline in the Treatment of Facial Acne Vulgaris

Phase 2

LAD603

Alopecia Areata

Phase 2

Clinical Trials (2)

NCT07311564A Study of LAD603 in Adults With Alopecia Areata

Phase 2

NCT06200597A Single and Multiple Ascending Dose Study of LAD603 in Healthy Subjects

Phase 1

LAD191

Hidradenitis Suppurativa

Phase 2

Clinical Trials (2)

NCT07151937A Study of LAD191 in Adults With Hidradenitis Suppurativa

Phase 2

NCT06488209Single and Multiple Ascending Dose Study in Healthy Participants and Participants With an Autoimmune Disease

Phase 1

LAS41003

Tinea Pedis

Phase 2

Clinical Trials (3)

NCT01096472Efficacy and Safety of LAS41003 in the Treatment of Inflammatory Tinea Pedis

Phase 2

NCT01020994Efficacy and Safety of LAS41003 in the Treatment of Superficial Infected Eczema

Phase 2

LAS41004

Chronic Obstructive Pulmonary Disease (COPD)

Phase 2

Clinical Trials (5)

NCT01119339Study to Investigate Dose-related Efficacy of LAS41004 in the Treatment of Psoriasis

Phase 2

NCT01283698Clinical Trial to Investigate Efficacy of LAS41004 in Psoriasis

Phase 2

LAS41002

Atopic Eczema

Phase 2

Genuair®

Phase 3

Clinical Trials (1)

NCT01915784Preference, Satisfaction and Ease of Use of Genuair® (Pressair™) and Breezhaler® (Neohaler™) Inhalers in Patients With COPD

Phase 3

Genuair®

Chronic Obstructive Pulmonary Disease (COPD)

Phase 3

Clinical Trials (1)

NCT01385696Study Evaluating Preference, Satisfaction and Ease of Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD) Diagnosed Patients

Phase 3

KX2-391

Phase 3

Clinical Trials (3)

NCT03285490A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on Actinic Keratosis on Face or Scalp (AK004)

Phase 3

NCT03285477A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on AK on Face or Scalp

cannabidiol/tetrahydrocannabinol

Multiple Sclerosis

Phase 3

5-fluorouracil/salicylic acid

Phase 3

Clinical Trials (1)

NCT02289768Study To Evaluate The Efficacy And Safety Of Actikerall® Solution In Patients With Grade I-II Actinic Keratoses

Phase 3

LAS41008

Chronic Obstructive Pulmonary Disease

Phase 3

Clinical Trials (2)

NCT01726933LAS41008 in Moderate to Severe Chronic Plaque Psoriasis

Phase 3

NCT02955693Study of the Effects of the Organism on Monomethyl Fumarate (MMF) After the Administration of LAS41008

Phase 1

terbinafine hydrochloride

Onychomycosis

Phase 3

Clinical Trials (1)

NCT03094468Study to Evaluate the Efficacy and Safety of P-3058 Nail Solution in the Treatment of Onychomycosis

Phase 3

calcipotriene

Nail Psoriasis

Phase 3

Clinical Trials (2)

NCT03079973Study to Evaluate the Efficacy and Safety of P-3073 Nail Solution in the Treatment of Mild to Moderate Psoriatic Fingernail/s

Phase 3

NCT05811234A Study to Assess Treatment Satisfaction, Patient-reported Outcomes, Effectiveness, and Safety of a Fixed-dose Combination of Calcipotriene/Betamethasone Dipropionate PAD Cream in the Treatment of Mild-to-moderate Plaque Psoriasis of the Scalp in Adults

aclidinium bromide

Phase 3

Dapsone Gel

Phase 3

Clinical Trials (1)

NCT01974141A Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris

Phase 3

Sativex®

Multiple Sclerosis

Phase 3

Clinical Trials (1)

NCT01538225Neurophysiological Study of Sativex in Multiple Sclerosis (MS) Spasticity

Phase 3

Dapsone Gel

Phase 3

Clinical Trials (1)

NCT01974323Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris

Phase 3

LAS41005

Phase 3

Clinical Trials (2)

NCT00987246Study on the Efficacy of LAS41005 in the Treatment of Actinic Keratosis

Phase 3

NCT01358851LAS41005 in Hyperkeratotic Actinic Keratosis

Phase 2

LAS41007

Chronic Obstructive Pulmonary Disease

Phase 3

Clinical Trials (2)

NCT01265602Double-blind, Randomized, Vehicle- and Comparator-controlled, Multi-center Trial to Evaluate the Efficacy and Safety of LAS41007 in the Treatment of Actinic Keratosis

Phase 3

NCT00991861Efficacy and Safety Study of LAS41007 in the Treatment of Actinic Keratosis

aclidinium

Phase 4

Clinical Trials (1)

NCT02039050Evaluation of Long-Acting Muscarinic Antagonists in COPD

Phase 4

tildrakizumab

Plaque Psoriasis

Phase 4

Clinical Trials (5)

NCT04229836Efficacy and Safety of Tildrakizumab 100 Milligrams (mg) in Participants With Moderate-Severe Chronic Plaque Psoriasis and Its Impact on Their Quality of Life (TRIBUTE)

Phase 4

NCT04263610Efficacy and Safety of Tildrakizumab in Participants With Moderate-to-Severe Chronic Plaque Psoriasis Who Are Non-Responders to Dimethyl Fumarate Therapy

lebrikizumab

Atopic Dermatitis

Phase 4

Clinical Trials (5)

NCT06906497Lebrikizumab in Moderate-to-severe Atopic Dermatitis

Phase 4

NCT05916365Long-term Safety and Efficacy of Lebrikizumab in Adult and Adolescent Participant With Moderate-to-Severe Atopic Dermatitis

Phase 3

Education, weight reduction and physical exercise

Knee Osteoarthritis

Phase 4

Clinical Trials (1)

NCT00462319ARTIST: ARThrose Intervention STandardisée

Phase 4

tirbanibulin

Recurrent Respiratory Tract Infections

Phase 4

Clinical Trials (5)

NCT05387525A Study of Tirbanibulin Ointment and Diclofenac Sodium Gel for the Treatment of Adult Participants With Actinic Keratosis on the Face or Scalp

Phase 4

NCT05741294A Study of Tirbanibulin on the Wellbeing of Participants With Actinic Keratoses

pidotimod

Phase 4

Clinical Trials (1)

NCT04322669Study of Pidotimod in Children With Recurrent Respiratory Tract Infections (RRI)

Phase 4

tiotropium

Chronic Obstructive Pulmonary Disease

Phase 4

dapsone gel

Phase 4

Clinical Trials (1)

NCT02959970Safety and Efficacy Trial of ACZONE (Dapsone) Gel, 7.5% in 9 to 11 Year-Old Patients With Acne Vulgaris

Phase 4

almotriptan

Migraine

Phase N/A

Clinical Trials (1)

NCT00725140Standardized sTudy With Almotriptan in eaRly Treatment of Migraine

N/A

sarecycline